Medios slips after lower earnings, narrowing guidance
BUZZ-Medios slips after lower earnings, narrowing guidance ** Shares in Medios ILM1k.DE slip about 3% after the German specialty pharma provider reported lower nine-month earnings despite revenue growth across all operating segments
** Nine-month revenue rose 6.7% to €1.63 billion ($1.83 billion), while adjusted EBITDA 5.2% to €66.7 million as price declines in Pharmaceutical Supply and higher material costs weighed on profitability
** Medios confirmed its full-year guidance but said it expects 2026 earnings to come at the lower end of its €88 million to €92 million range
** Up to the previous session's close, the stock has lost 21% YTD
($1 = 0.8908 euros)
(Reporting by Isabela Kruczynska and Kira Britten)
Recent news on Medios AG
See all newsBrief: Medios Approves New Share Buyback Program
Medios slips after lower earnings, narrowing guidance
Germany's Medios 9M EBITDA pre falls on price declines
Brief: Medios Sees EUR 3.4 Mln Annual Caelo Synergies From 2028/29
Brief: Luxempart: increased its stake in pharma services company Medios AG to over 20%